Nieuws

mrt
3

Weekly new calls from the National Institutes of Health (NIH) February 28, 2014

The National Institutes of Health's (NIH) mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability. It is the largest source of funding for medical research in the world, creating hundreds of thousands of high-quality jobs by funding thousands of scientists in universities and research institutions around the world.

These are the weekly NIH funding opportunities of February 28, 2014:
• Exploratory Clinical Trials of Novel Interventions for Mental Disorders (R21/R33): Letter of Intent Due Date(s) 30 days before the application due date. Application Due Date(s) June 17, 2014, October 17, 2014, and February 17, 2015, by 5:00 PM local time of applicant organization;
• Exploratory Clinical Trials of Novel Interventions for Mental Disorders (R33): Letter of Intent Due Date(s) 30 days prior to application due date. Application Due Date(s) June 17, 2014, October 17, 2014, and February 17, 2015, by 5:00 PM local time of applicant organization;
• Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01): Letter of Intent Due Date(s) 30 days before the application due date. Application Due Date(s) June 17, 2014, October 17, 2014, and February 17, 2015, by 5:00 PM local time of applicant organization;
• Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (Collaborative R01): Letter of Intent Due Date(s) 30 days before the application due date. Application Due Date(s) June 17, 2014, October 17, 2014, and February 17, 2015, by 5:00 PM local time of applicant organization;
• Pilot Effectiveness Studies and Services Research Grants (R34): Letter of Intent Due Date(s) 30 days before the application due date. Application Due Date(s) June 17, 2014, October 17, 2014, and February 17, 2015, by 5:00 PM local time of applicant organization;
• Family-Centered Self-Management of Chronic Conditions (R01): Application Receipt Date(s): Multiple dates, see announcement;
• Family-Centered Self-Management of Chronic Conditions (R21): Application Receipt Date(s): Multiple dates, see announcement;
• Alcohol-Induced Effects on Tissue Injury and Repair (R01): Application Receipt Date(s): Multiple dates, see announcement;
• Alcohol-Induced Effects on Tissue Injury and Repair (R21): Application Receipt Date(s): Multiple dates, see announcement;
• Strengthening Adherence to Antiretroviral-Based HIV Treatment and Prevention (R21): Application Receipt Date(s): Multiple dates, see announcement;
• Strengthening Adherence to Antiretroviral-Based HIV Treatment and Prevention (R01): Application Receipt Date(s): Multiple dates, see announcement;
• Targeted Basic Behavioral and Social Science and Intervention Development for HIV Prevention and Care (R01): Application Receipt Date(s): Multiple dates, see announcement;
• Targeted Basic Behavioral and Social Science and Intervention Development for HIV Prevention and Care (R21): Application Receipt Date(s): Multiple dates, see announcement;
• Improving Delivery of HIV Prevention and Treatment through Implementation Science and Translational Research (R21): Application Receipt Date(s): Multiple dates, see announcement;
• Accelerating Improvements in the HIV Care Continuum (R21): Application Receipt Date(s): Multiple dates, see announcement;
• Improving Delivery of HIV Prevention and Treatment through Implementation Science and Translational Research (R01): Application Receipt Date(s): Multiple dates, see announcement;
• Accelerating Improvements in the HIV Care Continuum (R01): Application Receipt Date(s): Multiple dates, see announcement;
• Advancing Structural Level Interventions Through Enhanced Understanding of Social Determinants in HIV Prevention and Care (R01): Application Receipt Date(s): Multiple dates, see announcement;
• Advancing Structural Level Interventions Through Enhanced Understanding of Social Determinants in HIV Prevention and Care (R21): Application Receipt Date(s): Multiple dates, see announcement;
• Quantitative Imaging for Evaluation of Response to Cancer Therapies (U01): Application Receipt Date(s): Multiple dates, see announcement;
• Technologies for Healthy Independent Living (R01): Letter of Intent Due Date(s) 30 days before the application due date. Application Due Date(s) September 23, 2014; September 23, 2015; September 23, 2016, by 5:00 PM local time of applicant organization;
• Design and Development of Novel Technologies for Healthy Independent Living (R21): Letter of Intent Due Date(s) 30 days before the application due date. Application Due Date(s) September 23, 2014; September 23, 2015; September 23, 2016, by 5:00 PM local time of applicant organization;
• Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) (U19): Letter of Intent Due Date(s) June 15, 2014; February 13, 2015.
 
For more active Requests for Applications (RFAs) and Program Announcements (PAs) please click here.

Terug naar overzicht